Library Subscription: Guest
Critical Reviews™ in Immunology

Published 6 issues per year

ISSN Print: 1040-8401

ISSN Online: 2162-6472

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 1.3 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 2.6 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00079 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.24 SJR: 0.429 SNIP: 0.287 CiteScore™:: 2.7 H-Index: 81

Indexed in

Human High Molecular Weight-Melanoma-Associated Antigen (HMW-MAA): A Melanoma Cell Surface Chondroitin Sulfate Proteoglycan (MSCP) with Biological and Clinical Significance

Volume 24, Issue 4, 2004, 30 pages
DOI: 10.1615/CritRevImmunol.v24.i4.40
Get accessGet access

ABSTRACT

The lack of effective conventional therapies for the treatment of advanced stage melanoma has stimulated interest in the application of novel strategies for the treatment of patients with malignant melanoma. Because of its expression in a large percentage of melanoma lesions and its restricted distribution in normal tissues, the high molecular weight-melanoma-associated antigen (HMW-MAA), also known as the melanoma chondroitin sulfate proteoglycan (MCSP), has been used to implement immunotherapy of melanoma. The potential clinical relevance of HMW-MAA/MCSP has stimulated investigations to characterize its structural properties and biological function in melanoma cells. Over the last 10 years, the field of HMW-MAA/MCSP research has seen tremendous growth. Specifically, a significant amount of information has been accumulated regarding (1) the structural characteristics of the HMW-MAA/MCSP, (2) its role in the biology of melanoma cells, and (3) the potential molecular mechanisms underlying the association between HMW-MAA/MCSP—specific immunity and survival prolongation in melanoma patients immunized with HMW-MAA/MCSP mimics. In this review, we summarize the characteristics of the HMW-MAA/MCSP in terms of its structure, antigenic profile, tissue distribution, and similarities with its counterparts in other animal species. Additionally, we discuss the role the HMW-MAA/MCSP plays in melanoma cell biology with emphasis on the recently identified signal transduction pathways triggered by the HMW-MAA/MCSP. Finally, we discuss the potential molecular mechanisms underlying the beneficial effect of anti-HMW-MAA/MCSP antibodies on the clinical course of the disease in patients with melanoma.

CITED BY
  1. Selvan Senthamil R., Carbonell Denysha J., Fowler Abner W., Beatty Andrea R., Ravindranath Mepur H., Dillman Robert O., Establishment of stable cell lines for personalized melanoma cell vaccine, Melanoma Research, 20, 4, 2010. Crossref

  2. Wen Yunfei, Makagiansar Irwan T., Fukushi Jun-ichi, Liu Fu-Tong, Fukuda Michiko N., Stallcup William B., Molecular basis of interaction between NG2 proteoglycan and galectin-3, Journal of Cellular Biochemistry, 98, 1, 2006. Crossref

  3. Lin Jingrong, Takata Minoru, Murata Hiroshi, Goto Yasufumi, Kido Kenji, Ferrone Soldano, Saida Toshiaki, Polyclonality of BRAF Mutations in Acquired Melanocytic Nevi , JNCI: Journal of the National Cancer Institute, 101, 20, 2009. Crossref

  4. Paul Asit K., Ciesielski Michael J., Sajjad Munawwar, Wang Xinhui, Ferrone Soldano, Abdel-Nabi Hani, Fenstermaker Robert A., Expression of HMP/AN2, a melanoma associated antigen, in murine cerebral gliomas: potential for radioimmunotargeting, Journal of Neuro-Oncology, 94, 1, 2009. Crossref

  5. Drake Allison S., Brady Michael T., Wang Xin Hui, Sait Sheila J. N., Earp Justin C., Ghoshal (Gupta) Sampa, Ferrone Soldano, Wang Eunice S., Wetzler Meir, Targeting 11q23 positive acute leukemia cells with high molecular weight-melanoma associated antigen-specific monoclonal antibodies, Cancer Immunology, Immunotherapy, 58, 3, 2009. Crossref

  6. Erfurt Cornelia, Müller Esther, Emmerling Sonja, Klotz Claudia, Hertl Michael, Schuler Gerold, Schultz Erwin S., Melanoma-associated chondroitin sulphate proteoglycan as a new target antigen for CD4+T cells in melanoma patients, International Journal of Cancer, 124, 10, 2009. Crossref

  7. Schwenkert Michael, Birkholz Katrin, Schwemmlein Michael, Kellner Christian, Kügler Markus, Peipp Matthias, Nettelbeck Dirk M., Schuler-Thurner Beatrice, Schaft Niels, Dörrie Jan, Ferrone Soldano, Kämpgen Eckhart, Fey Georg H., A single chain immunotoxin, targeting the melanoma-associated chondroitin sulfate proteoglycan, is a potent inducer of apoptosis in cultured human melanoma cells, Melanoma Research, 18, 2, 2008. Crossref

  8. Schultz E.S., Schuler G., Impfstrategien zur Behandlung des Melanoms, Der Hautarzt, 59, 10, 2008. Crossref

  9. Goto Yasufumi, Arigami Takaaki, Murali Rajmohan, Scolyer Richard A., Tanemura Atsushi, Takata Minoru, Turner Roderick R., Nguyen Linhda, Nguyen Tung, Morton Donald L., Ferone Soldano, Hoon Dave S.B., High molecular weight-melanoma-associated antigen as a biomarker of desmoplastic melanoma, Pigment Cell & Melanoma Research, 23, 1, 2010. Crossref

  10. Wang Xinhui, Osada Takuya, Wang Yangyang, Yu Ling, Sakakura Koichi, Katayama Akihiro, McCarthy James B., Brufsky Adam, Chivukula Mamatha, Khoury Thaer, Hsu David S., Barry William T., Lyerly H. Kim, Clay Timothy M., Ferrone Soldano, CSPG4 Protein as a New Target for the Antibody-Based Immunotherapy of Triple-Negative Breast Cancer, JNCI: Journal of the National Cancer Institute, 102, 19, 2010. Crossref

  11. Schwab Joseph H., Boland Patrick J., Agaram Narasimhan P., Socci Nicholas D., Guo Tianhua, O’Toole Gary C., Wang Xinhui, Ostroumov Elena, Hunter Christopher J., Block Joel A., Doty Stephen, Ferrone Soldano, Healey John H., Antonescu Cristina R., Chordoma and chondrosarcoma gene profile: implications for immunotherapy, Cancer Immunology, Immunotherapy, 58, 3, 2009. Crossref

  12. Yu Ling, Favoino Elvira, Wang Yangyang, Ma Yang, Deng Xiaojuan, Wang Xinhui, The CSPG4-specific monoclonal antibody enhances and prolongs the effects of the BRAF inhibitor in melanoma cells, Immunologic Research, 50, 2-3, 2011. Crossref

  13. Medic Sandra, Rizos Helen, Ziman Mel, Differential PAX3 functions in normal skin melanocytes and melanoma cells, Biochemical and Biophysical Research Communications, 411, 4, 2011. Crossref

  14. Leffers Ninke, Lambeck Annechien J.A., de Graeff Pauline, Bijlsma Astrid Y., Daemen Toos, van der Zee Ate G.J., Nijman Hans W., Survival of ovarian cancer patients overexpressing the tumour antigen p53 is diminished in case of MHC class I down-regulation, Gynecologic Oncology, 110, 3, 2008. Crossref

  15. Eubel Jana, Enk Alexander H, Dendritic cell vaccination as a treatment modality for melanoma, Expert Review of Anticancer Therapy, 9, 11, 2009. Crossref

  16. Pleshkan V. V., Zinovyeva M. V., Sverdlov E. D., Melanoma: Surface markers as the first point of targeted delivery of therapeutic genes in multilevel gene therapy, Molecular Biology, 45, 3, 2011. Crossref

  17. Mayayo Saray Lorda, Prestigio Simone, Maniscalco Lorella, Rosa Giuseppe La, Aricò Arianna, Maria Raffaella De, Cavallo Federica, Ferrone Soldano, Buracco Paolo, Iussich Selina, Chondroitin sulfate proteoglycan-4: A biomarker and a potential immunotherapeutic target for canine malignant melanoma, The Veterinary Journal, 190, 2, 2011. Crossref

  18. Lejeune Ferdy J, Rimoldi Donata, Speiser Daniel, New approaches in metastatic melanoma: biological and molecular targeted therapies, Expert Review of Anticancer Therapy, 7, 5, 2007. Crossref

  19. De Giorgi Vincenzo, Pinzani Pamela, Salvianti Francesca, Grazzini Marta, Orlando Claudio, Santucci Marco, Lotti Torello, Pazzagli Mario, Massi Daniela, Circulating Tumor Cells in Cutaneous Melanoma, Journal of Investigative Dermatology, 131, 8, 2011. Crossref

  20. Cooney Craig A, Jousheghany Fariba, Yao-Borengasser Aiwei, Phanavanh Bounleut, Gomes Tina, Kieber-Emmons Ann Marie, Siegel Eric R, Suva Larry J, Ferrone Soldano, Kieber-Emmons Thomas, Monzavi-Karbassi Behjatolah, Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11gene expression in forming surface P-selectin ligands in aggressive breast cancer cells, Breast Cancer Research, 13, 3, 2011. Crossref

  21. Tanaka Ryo, Koyanagi Kazuo, Narita Norihiko, Kuo Christine, Hoon Dave S.B., Prognostic molecular biomarkers for cutaneous malignant melanoma, Journal of Surgical Oncology, 104, 4, 2011. Crossref

  22. Nicolay Hugues JM, Sigalotti Luca, Fonsatti Ester, Covre Alessia, Parisi Giulia, Fratta Elisabetta, Coral Sandra, Maio Michele, Epigenetically regulated tumor-associated antigens in melanoma, Expert Review of Dermatology, 4, 2, 2009. Crossref

  23. Paterson Yvonne, Guirnalda Patrick D., Wood Laurence M., Listeria and Salmonella bacterial vectors of tumor-associated antigens for cancer immunotherapy, Seminars in Immunology, 22, 3, 2010. Crossref

  24. Lin J, Goto Y, Murata H, Sakaizawa K, Uchiyama A, Saida T, Takata M, Polyclonality of BRAF mutations in primary melanoma and the selection of mutant alleles during progression, British Journal of Cancer, 104, 3, 2011. Crossref

  25. Pan Jing, Qian Yi, Weiser Peter, Zhou Xiaodong, Lu Hong, Studelska Daniel R., Zhang Lijuan, Glycosaminoglycans and Activated Contact System in Cancer Patient Plasmas, in Glycosaminoglycans in Development, Health and Disease, 93, 2010. Crossref

  26. Wegrowski Yanusz, Maquart François‐Xavier, Chondroitin Sulfate Proteoglycans in Tumor Progression, in Chondroitin Sulfate: Structure, Role and Pharmacological Activity, 53, 2006. Crossref

  27. Wallecha Anu, Carroll Kyla Driscoll, Maciag Paulo Cesar, Rivera Sandra, Shahabi Vafa, Paterson Yvonne, , 66, 2009. Crossref

  28. Campoli Michael, Ferrone Soldano, Wang Xinhui, , 109, 2010. Crossref

  29. Sakaizawa K, Goto Y, Kiniwa Y, Uchiyama A, Harada K, Shimada S, Saida T, Ferrone S, Takata M, Uhara H, Okuyama R, Mutation analysis of BRAF and KIT in circulating melanoma cells at the single cell level, British Journal of Cancer, 106, 5, 2012. Crossref

  30. Khoja Leila, Lorigan Paul, Zhou Cong, Lancashire Matthew, Booth Jessica, Cummings Jeff, Califano Raffaele, Clack Glen, Hughes Andrew, Dive Caroline, Biomarker Utility of Circulating Tumor Cells in Metastatic Cutaneous Melanoma, Journal of Investigative Dermatology, 133, 6, 2013. Crossref

  31. Huang Feng-Ju, You Weon-Kyoo, Bonaldo Paolo, Seyfried Thomas N., Pasquale Elena B., Stallcup William B., Pericyte deficiencies lead to aberrant tumor vascularizaton in the brain of the NG2 null mouse, Developmental Biology, 344, 2, 2010. Crossref

  32. Lacy Katie E, Karagiannis Sophia N, Nestle Frank O, Immunotherapy for melanoma, Expert Review of Dermatology, 7, 1, 2012. Crossref

  33. Guirnalda Patrick, Wood Laurence, Paterson Yvonne, Listeria monocytogenes and Its Products as Agents for Cancer Immunotherapy, in Immunity to Listeria Monocytogenes, 113, 2012. Crossref

  34. Van Sinderen M., Cuman C., Winship A., Menkhorst E., Dimitriadis E., The chrondroitin sulfate proteoglycan (CSPG4) regulates human trophoblast function, Placenta, 34, 10, 2013. Crossref

  35. Takata Minoru, IdentifyingBRAFandKITmutations in melanoma, Expert Review of Dermatology, 8, 2, 2013. Crossref

  36. Bandarchi Bizhan, Jabbari Cyrus Aleksandre, Vedadi Ali, Navab Roya, Molecular biology of normal melanocytes and melanoma cells, Journal of Clinical Pathology, 66, 8, 2013. Crossref

  37. Karakousis Giorgos, Yang Ruifeng, Xu Xiaowei, Circulating Melanoma Cells as a Predictive Biomarker, Journal of Investigative Dermatology, 133, 6, 2013. Crossref

  38. Sabbatino Francesco, Wang Yangyang, Wang Xinhui, Schwab Joseph H., Ferrone Soldano, Ferrone Cristina R., Novel Tumor Antigen-Specific Monoclonal Antibody-Based Immunotherapy to Eradicate Both Differentiated Cancer Cells and Cancer-Initiating Cells in Solid Tumors, Seminars in Oncology, 41, 5, 2014. Crossref

  39. Alekseenko I. V., Zinovyeva M. V., Pleshkan V. V., Sverdlov E. D., Gene targeting in melanoma therapy: exploiting of surface markers and specific promoters, Biopolymers and Cell, 28, 1, 2012. Crossref

  40. Wood Laurence M., Paterson Yvonne, Attenuated Listeria monocytogenes: a powerful and versatile vector for the future of tumor immunotherapy, Frontiers in Cellular and Infection Microbiology, 4, 2014. Crossref

  41. Schubert Ingo, Kellner Christian, Stein Christoph, Kügler Markus, Schwenkert Michael, Saul Domenica, Mentz Kristin, Singer Heiko, Stockmeyer Bernhard, Hillen Wolfgang, Mackensen Andreas, Fey Georg H., A single-chain triplebody with specificity for CD19 and CD33 mediates effective lysis of mixed lineage leukemia cells by dual targeting, mAbs, 3, 1, 2011. Crossref

  42. Barucca A., Capitani M., Cesca M., Tomassoni D., Kazmi U., Concetti F., Vincenzetti L., Concetti A., Venanzi F. M., Recombinant DNA Technology for Melanoma Immunotherapy: Anti-Id DNA Vaccines Targeting High Molecular Weight Melanoma-Associated Antigen, Molecular Biotechnology, 56, 11, 2014. Crossref

  43. Rodic Stefan, Mihalcioiu Catalin, Saleh Ramy R., Detection methods of circulating tumor cells in cutaneous melanoma: A systematic review, Critical Reviews in Oncology/Hematology, 91, 1, 2014. Crossref

  44. Brehm Hannes, Niesen Judith, Mladenov Radoslav, Stein Christoph, Pardo Alessa, Fey Georg, Helfrich Wijnand, Fischer Rainer, Gattenlöhner Stefan, Barth Stefan, A CSPG4-specific immunotoxin kills rhabdomyosarcoma cells and binds to primary tumor tissues, Cancer Letters, 352, 2, 2014. Crossref

  45. Tschernia Nicholas, Orentas Rimas, Mackall Crystal, Chondroitin sulfate proteoglycan 4 specific chimeric antigen receptor therapy for pediatric solid tumors, Journal for ImmunoTherapy of Cancer, 2, S3, 2014. Crossref

  46. Chicaybam Leonardo, Bonamino Martin Hernan, Moving Receptor Redirected Adoptive Cell Therapy Toward Fine Tuning of Antitumor Responses, International Reviews of Immunology, 33, 5, 2014. Crossref

  47. Beard Rachel E, Zheng Zhili, Lagisetty Kiran H, Burns William R, Tran Eric, Hewitt Stephen M, Abate-Daga Daniel, Rosati Shannon F, Fine Howard A, Ferrone Soldano, Rosenberg Steven A, Morgan Richard A, Multiple chimeric antigen receptors successfully target chondroitin sulfate proteoglycan 4 in several different cancer histologies and cancer stem cells, Journal for ImmunoTherapy of Cancer, 2, 1, 2014. Crossref

  48. Barradas Ana, Terstappen Leon, Towards the Biological Understanding of CTC: Capture Technologies, Definitions and Potential to Create Metastasis, Cancers, 5, 4, 2013. Crossref

  49. Krug Christian, Birkholz Katrin, Paulus Alexander, Schwenkert Michael, Schmidt Patrick, Hoffmann Nicole, Hombach Andreas, Fey Georg, Abken Hinrich, Schuler Gerold, Schuler-Thurner Beatrice, Dörrie Jan, Schaft Niels, Stability and activity of MCSP-specific chimeric antigen receptors (CARs) depend on the scFv antigen-binding domain and the protein backbone, Cancer Immunology, Immunotherapy, 64, 12, 2015. Crossref

  50. Misra Suniti, Hascall Vincent C., Atanelishvili Ilia, Moreno Rodriguez Ricardo, Markwald Roger R., Ghatak Shibnath, Utilization of Glycosaminoglycans/Proteoglycans as Carriers for Targeted Therapy Delivery, International Journal of Cell Biology, 2015, 2015. Crossref

  51. Schoenfeld Andrew J., Wang Xinhui, Wang Yangyang, Hornicek Francis J., Nielsen G. Petur, Duan Zhenfeng, Ferrone Soldano, Schwab Joseph H., CSPG4 as a prognostic biomarker in chordoma, The Spine Journal, 16, 6, 2016. Crossref

  52. Ruiz Carmen, Li Julia, Luttgen Madelyn S, Kolatkar Anand, Kendall Jude T, Flores Edna, Topp Zheng, Samlowski Wolfram E, McClay Edward, Bethel Kelly, Ferrone Soldano, Hicks James, Kuhn Peter, Limited genomic heterogeneity of circulating melanoma cells in advanced stage patients, Physical Biology, 12, 1, 2015. Crossref

  53. Wang Yangyang, Geldres Claudia, Ferrone Soldano, Dotti Gianpietro, Chondroitin sulfate proteoglycan 4 as a target for chimeric antigen receptor-based T-cell immunotherapy of solid tumors, Expert Opinion on Therapeutic Targets, 19, 10, 2015. Crossref

  54. Selbo Pål Kristian, Bostad Monica, Olsen Cathrine Elisabeth, Edwards Victoria Tudor, Høgset Anders, Weyergang Anette, Berg Kristian, Photochemical internalisation, a minimally invasive strategy for light-controlled endosomal escape of cancer stem cell-targeting therapeutics, Photochemical & Photobiological Sciences, 14, 8, 2015. Crossref

  55. Amoury Manal, Mladenov Radoslav, Nachreiner Thomas, Pham Anh-Tuan, Hristodorov Dmitrij, Di Fiore Stefano, Helfrich Wijnand, Pardo Alessa, Fey Georg, Schwenkert Michael, Thepen Theophilus, Kiessling Fabian, Hussain Ahmad F., Fischer Rainer, Kolberg Katharina, Barth Stefan, A novel approach for targeted elimination of CSPG4-positive triple-negative breast cancer cells using a MAP tau-based fusion protein, International Journal of Cancer, 139, 4, 2016. Crossref

  56. Uslu Ugur, Schuler Gerold, Dörrie Jan, Schaft Niels, Combining a chimeric antigen receptor and a conventional T-cell receptor to generate T cells expressing two additional receptors (TETARs) for a multi-hit immunotherapy of melanoma, Experimental Dermatology, 25, 11, 2016. Crossref

  57. Gilbert Amy E., Karagiannis Panagiotis, Dodev Tihomir, Koers Alexander, Lacy Katie, Josephs Debra H., Takhar Pooja, Geh Jenny L. C., Healy Ciaran, Harries Mark, Acland Katharine M., Rudman Sarah M., Beavil Rebecca L., Blower Philip J., Beavil Andrew J., Gould Hannah J., Spicer James, Nestle Frank O., Karagiannis Sophia N., Lu Shan, Monitoring the Systemic Human Memory B Cell Compartment of Melanoma Patients for Anti-Tumor IgG Antibodies, PLoS ONE, 6, 4, 2011. Crossref

  58. O’ Reilly Eimear, Tirincsi Andrea, Logue Susan E., Szegezdi Eva, The Janus Face of Death Receptor Signaling during Tumor Immunoediting, Frontiers in Immunology, 7, 2016. Crossref

  59. Latzka Julia, Gaier Sonja, Hofstetter Gerlinde, Balazs Nina, Smole Ursula, Ferrone Soldano, Scheiner Otto, Breiteneder Heimo, Pehamberger Hubert, Wagner Stefan, Herlyn Meenhard, Specificity of Mimotope-Induced Anti-High Molecular Weight-Melanoma Associated Antigen (HMW-MAA) Antibodies Does Not Ensure Biological Activity, PLoS ONE, 6, 5, 2011. Crossref

  60. Tsao Simon Chang-Hao, Vaidyanathan Ramanathan, Dey Shuvashis, Carrascosa Laura G., Christophi Christopher, Cebon Jonathan, Shiddiky Muhammad J. A., Behren Andreas, Trau Matt, Capture and On-chip analysis of Melanoma Cells Using Tunable Surface Shear forces, Scientific Reports, 6, 1, 2016. Crossref

  61. Maquart François-Xavier, Brézillon Stéphane, Wegrowski Yanusz, Proteoglycans in Skin Aging, in Textbook of Aging Skin, 2017. Crossref

  62. Fu JingJing, Shi ZhuanZhuan, Li Man, Wang Yangyang, Yu Ling, Label-Free Detection of Chondroitin Sulphate Proteoglycan 4 by a Polyaniline/Graphene Nanocomposite Functionalized Impedimetric Immunosensor, Journal of Nanomaterials, 2016, 2016. Crossref

  63. He Yuan, Hendriks Djoke, van Ginkel Robert, Samplonius Douwe, Bremer Edwin, Helfrich Wijnand, Melanoma-Directed Activation of Apoptosis Using a Bispecific Antibody Directed at MCSP and TRAIL Receptor-2/Death Receptor-5, Journal of Investigative Dermatology, 136, 2, 2016. Crossref

  64. Selbo Pål K., Rosenblum Michael G., Cheung Lawrence H., Zhang Wendy, Berg Kristian, Bauer Joseph Alan, Multi-Modality Therapeutics with Potent Anti-Tumor Effects: Photochemical Internalization Enhances Delivery of the Fusion Toxin scFvMEL/rGel, PLoS ONE, 4, 8, 2009. Crossref

  65. Jordaan Sandra, Chetty Shivan, Mungra Neelakshi, Koopmans Iris, van Bommel Peter, Helfrich Wijnand, Barth Stefan, CSPG4: A Target for Selective Delivery of Human Cytolytic Fusion Proteins and TRAIL, Biomedicines, 5, 4, 2017. Crossref

  66. Harrer Dennis C., Simon Bianca, Fujii Shin-ichiro, Shimizu Kanako, Uslu Ugur, Schuler Gerold, Gerer Kerstin F., Hoyer Stefanie, Dörrie Jan, Schaft Niels, RNA-transfection of γ/δ T cells with a chimeric antigen receptor or an α/β T-cell receptor: a safer alternative to genetically engineered α/β T cells for the immunotherapy of melanoma, BMC Cancer, 17, 1, 2017. Crossref

  67. Bolhassani Azam, Naderi Niloofar, Soleymani Sepehr, Prospects and progress ofListeria-based cancer vaccines, Expert Opinion on Biological Therapy, 2017. Crossref

  68. Rolih Valeria, Barutello Giuseppina, Iussich Selina, De Maria Raffaella, Quaglino Elena, Buracco Paolo, Cavallo Federica, Riccardo Federica, CSPG4: a prototype oncoantigen for translational immunotherapy studies, Journal of Translational Medicine, 15, 1, 2017. Crossref

  69. Jia Zhenyu, Lee Chung, Zi Xiaolin, McClelland Michael, Mercola Dan, Tumor Microenvironment: Prospects for Diagnosis and Prognosis of Prostate Cancer Based on Changes in Tumor-Adjacent Stroma, in Precision Molecular Pathology of Prostate Cancer, 2018. Crossref

  70. Eng M. S., Kaur J., Prasmickaite L., Engesæter B. Ø., Weyergang A., Skarpen E., Berg K., Rosenblum M. G., Mælandsmo G. M., Høgset A., Ferrone S., Selbo P. K., Enhanced targeting of triple-negative breast carcinoma and malignant melanoma by photochemical internalization of CSPG4-targeting immunotoxins, Photochemical & Photobiological Sciences, 17, 5, 2018. Crossref

  71. Sharma Priyanka, Ludwig Sonja, Muller Laurent, Hong Chang Sook, Kirkwood John M, Ferrone Soldano, Whiteside Theresa L., Immunoaffinity-based isolation of melanoma cell-derived exosomes from plasma of patients with melanoma, Journal of Extracellular Vesicles, 7, 1, 2018. Crossref

  72. Fisher Jonathan, Anderson John, Engineering Approaches in Human Gamma Delta T Cells for Cancer Immunotherapy, Frontiers in Immunology, 9, 2018. Crossref

  73. Kasten Benjamin, Oliver Patsy, Kim Harrison, Fan Jinda, Ferrone Soldano, Zinn Kurt, Buchsbaum Donald, 212Pb-Labeled Antibody 225.28 Targeted to Chondroitin Sulfate Proteoglycan 4 for Triple-Negative Breast Cancer Therapy in Mouse Models, International Journal of Molecular Sciences, 19, 4, 2018. Crossref

  74. Marsavela G., Aya-Bonilla C.A., Warkiani M.E., Gray E.S., Ziman M., Melanoma circulating tumor cells: Benefits and challenges required for clinical application, Cancer Letters, 424, 2018. Crossref

  75. Tsao Simon Chang-Hao, Wang Jing, Wang Yuling, Behren Andreas, Cebon Jonathan, Trau Matt, Characterising the phenotypic evolution of circulating tumour cells during treatment, Nature Communications, 9, 1, 2018. Crossref

  76. Ilieva Kristina M., Cheung Anthony, Mele Silvia, Chiaruttini Giulia, Crescioli Silvia, Griffin Merope, Nakamura Mano, Spicer James F., Tsoka Sophia, Lacy Katie E., Tutt Andrew N. J., Karagiannis Sophia N., Chondroitin Sulfate Proteoglycan 4 and Its Potential As an Antibody Immunotherapy Target across Different Tumor Types, Frontiers in Immunology, 8, 2018. Crossref

  77. Simon Bianca, Uslu Ugur, CAR‐T cell therapy in melanoma: A future success story?, Experimental Dermatology, 27, 12, 2018. Crossref

  78. Simon Bianca, Wiesinger Manuel, März Johannes, Wistuba-Hamprecht Kilian, Weide Benjamin, Schuler-Thurner Beatrice, Schuler Gerold, Dörrie Jan, Uslu Ugur, The Generation of CAR-Transfected Natural Killer T Cells for the Immunotherapy of Melanoma, International Journal of Molecular Sciences, 19, 8, 2018. Crossref

  79. Dörrie Jan, Babalija Lek, Hoyer Stefanie, Gerer Kerstin, Schuler Gerold, Heinzerling Lucie, Schaft Niels, BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells: Consequences for Adoptive T-Cell Therapy, International Journal of Molecular Sciences, 19, 1, 2018. Crossref

  80. Simon Bianca, Harrer Dennis C., Schuler-Thurner Beatrice, Schaft Niels, Schuler Gerold, Dörrie Jan, Uslu Ugur, The siRNA-mediated downregulation of PD-1 alone or simultaneously with CTLA-4 shows enhanced in vitro CAR-T-cell functionality for further clinical development towards the potential use in immunotherapy of melanoma, Experimental Dermatology, 27, 7, 2018. Crossref

  81. Knol Anne C., Nguyen Jean-Michel, Pandolfino Marie-Christine, Denis Marc G., Khammari Amir, Dréno Brigitte, PD-L1 expression by tumor cell lines: A predictive marker in melanoma, Experimental Dermatology, 27, 6, 2018. Crossref

  82. Harrer Dennis C., Schuler Gerold, Dörrie Jan, Schaft Niels, CSPG4-Specific CAR T Cells for High-Risk Childhood B Cell Precursor Leukemia, International Journal of Molecular Sciences, 20, 11, 2019. Crossref

  83. Erfurt Cornelia, Sun Zhaojun, Haendle Ina, Schuler-Thurner Beatrice, Heirman Carlo, Thielemans Kris, van der Bruggen Pierre, Schuler Gerold, Schultz Erwin S., Tumor-Reactive CD4+ T Cell Responses to the Melanoma-Associated Chondroitin Sulphate Proteoglycan in Melanoma Patients and Healthy Individuals in the Absence of Autoimmunity, The Journal of Immunology, 178, 12, 2007. Crossref

  84. Bailey Jarrod, An Examination of Chimpanzee Use in Human Cancer Research, Alternatives to Laboratory Animals, 37, 4, 2009. Crossref

  85. Aya-Bonilla Carlos, Gray Elin, Manikandan Jayapal, Freeman James, Zaenker Pauline, Reid Anna, Khattak Muhammad, Frank Markus, Millward Michael, Ziman Mel, Immunomagnetic-Enriched Subpopulations of Melanoma Circulating Tumour Cells (CTCs) Exhibit Distinct Transcriptome Profiles, Cancers, 11, 2, 2019. Crossref

  86. Sanderson Ralph D., Yang Yang, Purushothaman Anurag, Khotskaya Yekaterina B., Ritchie Joseph P., Ramani Vishnu C., Proteoglycans and Cancer, in Cell-Extracellular Matrix Interactions in Cancer, 2010. Crossref

  87. Padayachee Eden Rebecca, Adeola Henry Ademola, Van Wyk Jennifer Catherine, Nsole Biteghe Fleury Augustine, Chetty Shivan, Khumalo Nonhlanhla Patience, Barth Stefan, Applications of SNAP-tag technology in skin cancer therapy, Health Science Reports, 2, 2, 2019. Crossref

  88. Wang Yangyang, Sabbatino Francesco, Wang Xinhui, Ferrone Soldano, Detection of Chondroitin Sulfate Proteoglycan 4 (CSPG4) in Melanoma, in Molecular Diagnostics for Melanoma, 1102, 2014. Crossref

  89. Tarone Lidia, Barutello Giuseppina, Iussich Selina, Giacobino Davide, Quaglino Elena, Buracco Paolo, Cavallo Federica, Riccardo Federica, Naturally occurring cancers in pet dogs as pre-clinical models for cancer immunotherapy, Cancer Immunology, Immunotherapy, 68, 11, 2019. Crossref

  90. Wang Yangyang, Sabbatino Francesco, Yu Ling, Favoino Elvira, Wang Xinhui, Ligorio Matteo, Ferrone Soldano, Schwab Joseph H., Ferrone Cristina R., Tumor Antigen-Specific Monoclonal Antibody-Based Immunotherapy, Cancer Initiating Cells and Disease Recurrence, in Resistance to Immunotherapeutic Antibodies in Cancer, 2, 2013. Crossref

  91. Maquart François-Xavier, Brézillon Stéphane, Wegrowski Yanusz, Proteoglycans in Skin Aging, in Textbook of Aging Skin, 2010. Crossref

  92. Maquart François-Xavier, Brézillon Stéphane, Wegrowski Yanusz, Proteoglycans in Skin Aging, in Textbook of Aging Skin, 2015. Crossref

  93. Simon Bianca, Harrer Dennis C., Schuler-Thurner Beatrice, Schuler Gerold, Uslu Ugur, Arming T Cells with a gp100-Specific TCR and a CSPG4-Specific CAR Using Combined DNA- and RNA-Based Receptor Transfer, Cancers, 11, 5, 2019. Crossref

  94. Boire Adrienne, Brandsma Dieta, Brastianos Priscilla K, Le Rhun Emilie, Ahluwalia Manmeet, Junck Larry, Glantz Michael, Groves Morris D, Lee Eudocia Q, Lin Nancy, Raizer Jeffrey, Rudà Roberta, Weller Michael, Van den Bent Martin J, Vogelbaum Michael A, Chang Susan, Wen Patrick Y, Soffietti Riccardo, Liquid biopsy in central nervous system metastases: a RANO review and proposals for clinical applications, Neuro-Oncology, 21, 5, 2019. Crossref

  95. Le Rhun Emilie, Weller Michael, Clinical, Imaging, and CSF Cytological Presentation of Leptomeningeal Metastases from Solid Non-CNS Primary Tumors, in Central Nervous System Metastases, 2020. Crossref

  96. Wiesinger Manuel, März Johannes, Kummer Mirko, Schuler Gerold, Dörrie Jan, Schuler-Thurner Beatrice, Schaft Niels, Clinical-Scale Production of CAR-T Cells for the Treatment of Melanoma Patients by mRNA Transfection of a CSPG4-Specific CAR under Full GMP Compliance, Cancers, 11, 8, 2019. Crossref

  97. Ferrone S., Whiteside T. L., Targeting CSPG4 for isolation of melanoma cell-derived exosomes from body fluids, HNO, 68, 2, 2020. Crossref

  98. Sharma Priyanka, Diergaarde Brenda, Ferrone Soldano, Kirkwood John M., Whiteside Theresa L., Melanoma cell-derived exosomes in plasma of melanoma patients suppress functions of immune effector cells, Scientific Reports, 10, 1, 2020. Crossref

  99. Kiewe P., Bechrakis N.E., Schmittel A., Ruf P., Lindhofer H., Thiel E., Nagorsen D., Increased chondroitin sulphate proteoglycan expression (B5 immunoreactivity) in metastases of uveal melanoma, Annals of Oncology, 17, 12, 2006. Crossref

  100. Mitra Akash, Andrews Miles C., Roh Whijae, De Macedo Marianna Petaccia, Hudgens Courtney W., Carapeto Fernando, Singh Shailbala, Reuben Alexandre, Wang Feng, Mao Xizeng, Song Xingzhi, Wani Khalida, Tippen Samantha, Ng Kwok-Shing, Schalck Aislyn, Sakellariou-Thompson Donald A., Chen Eveline, Reddy Sangeetha M., Spencer Christine N., Wiesnoski Diana, Little Latasha D., Gumbs Curtis, Cooper Zachary A., Burton Elizabeth M., Hwu Patrick, Davies Michael A., Zhang Jianhua, Bernatchez Chantale, Navin Nicholas, Sharma Padmanee, Allison James P., Wargo Jennifer A., Yee Cassian, Tetzlaff Michael T., Hwu Wen-Jen, Lazar Alexander J., Futreal P. Andrew, Spatially resolved analyses link genomic and immune diversity and reveal unfavorable neutrophil activation in melanoma, Nature Communications, 11, 1, 2020. Crossref

  101. Hofmann Linda, Ludwig Sonja, Vahl Julius M., Brunner Cornelia, Hoffmann Thomas K., Theodoraki Marie-Nicole, The Emerging Role of Exosomes in Diagnosis, Prognosis, and Therapy in Head and Neck Cancer, International Journal of Molecular Sciences, 21, 11, 2020. Crossref

  102. Kitago Minoru, Koyanagi Kazuo, Nakamura Takeshi, Goto Yasufumi, Faries Mark, O'Day Steven J, Morton Donald L, Ferrone Soldano, Hoon Dave S B, mRNA Expression and BRAF Mutation in Circulating Melanoma Cells Isolated from Peripheral Blood with High Molecular Weight Melanoma-Associated Antigen-Specific Monoclonal Antibody Beads, Clinical Chemistry, 55, 4, 2009. Crossref

  103. Simon Bianca, Uslu Ugur, Fasten the seat belt: Increasing safety of CAR T‐cell therapy, Experimental Dermatology, 29, 11, 2020. Crossref

  104. Hellmich Luisa, Witte Kai-Erik, Ebinger Martin, Ulmer Anja, Flow Cytometry for Detection and Quantification of Micrometastases in Sentinel Lymph Nodes from Patients with Primary Melanoma, Journal of Surgical Research, 257, 2021. Crossref

  105. Madheswaran Suresh, Mungra Neelakshi, Biteghe Fleury A.N., De la Croix Ndong Jean, Arowolo Afolake T., Adeola Henry A., Ramamurthy Dharanidharan, Naran Krupa, Khumalo Nonhlanhla P., Barth Stefan, Antibody-Based Targeted Interventions for the Diagnosis and Treatment of Skin Cancers, Anti-Cancer Agents in Medicinal Chemistry, 21, 2, 2020. Crossref

  106. Kamińska Paula, Buszka Karolina, Zabel Maciej, Nowicki Michał, Alix-Panabières Catherine, Budna-Tukan Joanna, Liquid Biopsy in Melanoma: Significance in Diagnostics, Prediction and Treatment Monitoring, International Journal of Molecular Sciences, 22, 18, 2021. Crossref

  107. Giacobino Davide, Camerino Mariateresa, Riccardo Federica, Cavallo Federica, Tarone Lidia, Martano Marina, Dentini Alfredo, Iussich Selina, Lardone Elena, Franci Paolo, Valazza Alberto, Manassero Luca, Del Magno Sara, De Maria Raffaella, Morello Emanuela, Buracco Paolo, Difference in outcome between curative intent vs marginal excision as a first treatment in dogs with oral malignant melanoma and the impact of adjuvant CSPG4‐DNA electrovaccination: A retrospective study on 155 cases , Veterinary and Comparative Oncology, 19, 4, 2021. Crossref

  108. Beasley Aaron B., Isaacs Timothy W., Vermeulen Tersia, Freeman James, DeSousa Jean-Louis, Bhikoo Riyaz, Hennessy Doireann, Reid Anna, Chen Fred K., Bentel Jacqueline, McKay Daniel, Conway R. Max, Pereira Michelle R., Mirzai Bob, Calapre Leslie, Erber Wendy N., Ziman Melanie R., Gray Elin S., Analysis of Circulating Tumour Cells in Early-Stage Uveal Melanoma: Evaluation of Tumour Marker Expression to Increase Capture, Cancers, 13, 23, 2021. Crossref

  109. Oliveira Giacomo, Stromhaug Kari, Klaeger Susan, Kula Tomasz, Frederick Dennie T., Le Phuong M., Forman Juliet, Huang Teddy, Li Shuqiang, Zhang Wandi, Xu Qikai, Cieri Nicoletta, Clauser Karl R., Shukla Sachet A., Neuberg Donna, Justesen Sune, MacBeath Gavin, Carr Steven A., Fritsch Edward F., Hacohen Nir, Sade-Feldman Moshe, Livak Kenneth J., Boland Genevieve M., Ott Patrick A., Keskin Derin B., Wu Catherine J., Phenotype, specificity and avidity of antitumour CD8+ T cells in melanoma, Nature, 596, 7870, 2021. Crossref

  110. Selvaraj Jubie, Prabha Thangavelu, Yadav Neetu, Identification of Drug Candidates for Breast Cancer Therapy Through Scaffold Repurposing: A Brief Review, Current Drug Research Reviews, 13, 1, 2021. Crossref

  111. van Vliet Amanda A., Georgoudaki Anna-Maria, Raimo Monica, de Gruijl Tanja D., Spanholtz Jan, Adoptive NK Cell Therapy: A Promising Treatment Prospect for Metastatic Melanoma, Cancers, 13, 18, 2021. Crossref

  112. Maurer Margarita, Müller André C., Wagner Christine, Huber Marie L., Rudashevskaya Elena L., Wagner Stephan N., Bennett Keiryn L., Combining Filter-Aided Sample Preparation and Pseudoshotgun Technology To Profile the Proteome of a Low Number of Early Passage Human Melanoma Cells, Journal of Proteome Research, 12, 2, 2013. Crossref

  113. Pellerino Alessia, Brastianos Priscilla K., Rudà Roberta, Soffietti Riccardo, Leptomeningeal Metastases from Solid Tumors: Recent Advances in Diagnosis and Molecular Approaches, Cancers, 13, 12, 2021. Crossref

  114. Xu Xinjie, Huang Shengkang, Xiao Xinyi, Sun Qihang, Liang Xiaoqian, Chen Sifei, Zhao Zijing, Huo Zhaochang, Tu Sanfang, Li Yuhua, Challenges and Clinical Strategies of CAR T-Cell Therapy for Acute Lymphoblastic Leukemia: Overview and Developments, Frontiers in Immunology, 11, 2021. Crossref

  115. de Bruyn Marco, Rybczynska Anna A, Wei Yunwei, Schwenkert Michael, Fey Georg H, Dierckx Rudi AJO, van Waarde Aren, Helfrich Wijnand, Bremer Edwin, Melanoma-associated Chondroitin Sulfate Proteoglycan (MCSP)-targeted delivery of soluble TRAIL potently inhibits melanoma outgrowth in vitro and in vivo, Molecular Cancer, 9, 1, 2010. Crossref

  116. Mondal Sujan Kumar, Whiteside Theresa L., Immunoaffinity-Based Isolation of Melanoma Cell-Derived and T Cell-Derived Exosomes from Plasma of Melanoma Patients, in Melanoma, 2265, 2021. Crossref

  117. Fenton Moon, Whiteside Theresa L., Ferrone Soldano, Boyiadzis Michael, Chondroitin Sulfate Proteoglycan-4 (CSPG4)-Specific Monoclonal Antibody 225.28 in Detection of Acute Myeloid Leukemia Blasts, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, 22, 2, 2015. Crossref

  118. Guirnalda Patrick, Wood Laurence, Seavey Matthew, Paterson Yvonne, Intracellular Facultative Bacterial Vectors for Cancer Immunotherapy, in Vaccinology, 2012. Crossref

  119. Giuliano Antonio, Companion Animal Model in Translational Oncology; Feline Oral Squamous Cell Carcinoma and Canine Oral Melanoma, Biology, 11, 1, 2021. Crossref

  120. Issaeva Irina, Zonis Yulia, Rozovskaia Tanya, Orlovsky Kira, Croce Carlo M., Nakamura Tatsuya, Mazo Alex, Eisenbach Lea, Canaani Eli, Knockdown of ALR (MLL2) Reveals ALR Target Genes and Leads to Alterations in Cell Adhesion and Growth, Molecular and Cellular Biology, 27, 5, 2007. Crossref

  121. Hanly Ailish, Gibson Frederick, Alani Rhoda M., Predictive Biomarkers of Melanoma, in Melanoma in Clinical Practice, 2021. Crossref

  122. Maciag Paulo Cesar, Seavey Matthew M., Pan Zhen-Kun, Ferrone Soldano, Paterson Yvonne, Cancer Immunotherapy Targeting the High Molecular Weight Melanoma-Associated Antigen Protein Results in a Broad Antitumor Response and Reduction of Pericytes in the Tumor Vasculature, Cancer Research, 68, 19, 2008. Crossref

  123. Goto Yasufumi, Arigami Takaaki, Kitago Minoru, Nguyen Sandy L., Narita Norihiko, Ferrone Soldano, Morton Donald L., Irie Reiko F., Hoon Dave S.B., Activation of toll-like receptors 2, 3, and 4 on human melanoma cells induces inflammatory factors, Molecular Cancer Therapeutics, 7, 11, 2008. Crossref

  124. Rivera Zeyana, Ferrone Soldano, Wang Xinhui, Jube Sandro, Yang Haining, Pass Harvey I., Kanodia Shreya, Gaudino Giovanni, Carbone Michele, CSPG4 as a Target of Antibody-Based Immunotherapy for Malignant Mesothelioma, Clinical Cancer Research, 18, 19, 2012. Crossref

  125. Dong Ruoyu, Zhang Yixi, Xiao Haowen, Zeng Xun, Engineering γδ T Cells: Recognizing and Activating on Their Own Way, Frontiers in Immunology, 13, 2022. Crossref

  126. Kawano Kouichiro, Ferrone Soldano, Ioannides Constantin G., Functional Idiotopes: Tumor Antigen–Directed Expression of CD8+ T-Cell Epitopes Nested in Unique NH2-terminal VH Sequence of Antiidiotypic Antibodies?, Cancer Research, 65, 14, 2005. Crossref

  127. Geldres Claudia, Savoldo Barbara, Hoyos Valentina, Caruana Ignazio, Zhang Ming, Yvon Eric, Del Vecchio Michele, Creighton Chad J., Ittmann Michael, Ferrone Soldano, Dotti Gianpietro, T Lymphocytes Redirected against the Chondroitin Sulfate Proteoglycan-4 Control the Growth of Multiple Solid Tumors both In Vitro and In Vivo , Clinical Cancer Research, 20, 4, 2014. Crossref

  128. Dörrie Jan, Birkholz Katrin, Schaft Niels, Strategies for immune intervention; from bench to bedside, Cancer Immunology, Immunotherapy, 56, 10, 2007. Crossref

  129. Juanes-Velasco Pablo, Galicia Norma, Pin Elisa, Jara-Acevedo Ricardo, Carabias-Sánchez Javier, García-Valiente Rodrigo, Lecrevisse Quentin, Pedreira Carlos Eduardo, Gongora Rafael, Sanchez-Santos Jose Manuel, Lorenzo-Gil Héctor, Landeira-Viñuela Alicia, Bareke Halin, Orfao Alberto, Nilsson Peter, Fuentes Manuel, Deciphering Biomarkers for Leptomeningeal Metastasis in Malignant Hemopathies (Lymphoma/Leukemia) Patients by Comprehensive Multipronged Proteomics Characterization of Cerebrospinal Fluid, Cancers, 14, 2, 2022. Crossref

  130. Chang Chien-Chung, Hernandez-Guzman Francisco G., Luo Wei, Wang Xinhui, Ferrone Soldano, Ghosh Debashis, Structural Basis of Antigen Mimicry in a Clinically Relevant Melanoma Antigen System, Journal of Biological Chemistry, 280, 50, 2005. Crossref

  131. Luo W, Wang X, Kageshita T, Wakasugi S, Karpf A R, Ferrone S, Regulation of high molecular weight-melanoma associated antigen (HMW-MAA) gene expression by promoter DNA methylation in human melanoma cells, Oncogene, 25, 20, 2006. Crossref

  132. Hsu Shu-Hsuan Claire, Nadesan Puviindran, Puviindran Vijitha, Stallcup William B., Kirsch David G., Alman Benjamin A., Effects of chondroitin sulfate proteoglycan 4 (NG2/CSPG4) on soft-tissue sarcoma growth depend on tumor developmental stage, Journal of Biological Chemistry, 293, 7, 2018. Crossref

  133. Goto Yasufumi, Ferrone Soldano, Arigami Takaaki, Kitago Minoru, Tanemura Atsushi, Sunami Eiji, Nguyen Sandy L., Turner Roderick R., Morton Donald L., Hoon Dave S.B., Human High Molecular Weight–Melanoma-Associated Antigen: Utility for Detection of Metastatic Melanoma in Sentinel Lymph Nodes, Clinical Cancer Research, 14, 11, 2008. Crossref

  134. Lattmann Evelyn, Levesque Mitchell P., The Role of Extracellular Vesicles in Melanoma Progression, Cancers, 14, 13, 2022. Crossref

  135. Schmidt Patrick, Kopecky Caroline, Hombach Andreas, Zigrino Paola, Mauch Cornelia, Abken Hinrich, Eradication of melanomas by targeted elimination of a minor subset of tumor cells, Proceedings of the National Academy of Sciences, 108, 6, 2011. Crossref

  136. Wagner Stefan, Krepler Clemens, Allwardt Dorothee, Latzka Julia, Strommer Sabine, Scheiner Otto, Pehamberger Hubert, Wiedermann Ursula, Hafner Christine, Breiteneder Heimo, Reduction of Human Melanoma Tumor Growth in Severe Combined Immunodeficient Mice by Passive Transfer of Antibodies Induced by a High Molecular Weight Melanoma-Associated Antigen Mimotope Vaccine, Clinical Cancer Research, 14, 24, 2008. Crossref

  137. Chekenya M, Krakstad C, Svendsen A, Netland I A, Staalesen V, Tysnes B B, Selheim F, Wang J, Sakariassen P Ø, Sandal T, Lønning P E, Flatmark T, Enger P Ø, Bjerkvig R, Sioud M, Stallcup W B, The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling, Oncogene, 27, 39, 2008. Crossref

  138. Burns William R., Zhao Yangbing, Frankel Timothy L., Hinrichs Christian S., Zheng Zhili, Xu Hui, Feldman Steven A., Ferrone Soldano, Rosenberg Steven A., Morgan Richard A., A High Molecular Weight Melanoma-Associated Antigen–Specific Chimeric Antigen Receptor Redirects Lymphocytes to Target Human Melanomas, Cancer Research, 70, 8, 2010. Crossref

  139. Camerino Mariateresa, Giacobino Davide, Manassero Luca, Iussich Selina, Riccardo Federica, Cavallo Federica, Tarone Lidia, Olimpo Matteo, Lardone Elena, Martano Marina, Del Magno Sara, Buracco Paolo, Morello Emanuela, Prognostic impact of bone invasion in canine oral malignant melanoma treated by surgery and anti‐CSPG4 vaccination: A retrospective study on 68 cases (2010–2020) , Veterinary and Comparative Oncology, 20, 1, 2022. Crossref

  140. Safarzadeh Kozani Pouya, Safarzadeh Kozani Pooria, O'Connor Roddy S., In Like a Lamb; Out Like a Lion: Marching CAR T Cells Toward Enhanced Efficacy in B-ALL, Molecular Cancer Therapeutics, 20, 7, 2021. Crossref

  141. Wang Xinhui, Katayama Akihiro, Wang Yangyang, Yu Ling, Favoino Elvira, Sakakura Koichi, Favole Alessandra, Tsuchikawa Takahiro, Silver Susan, Watkins Simon C., Kageshita Toshiro, Ferrone Soldano, Functional Characterization of an scFv-Fc Antibody that Immunotherapeutically Targets the Common Cancer Cell Surface Proteoglycan CSPG4, Cancer Research, 71, 24, 2011. Crossref

  142. Yang Jianbo, Price Matthew A., Li Gui Yuan, Bar-Eli Menashe, Salgia Ravi, Jagedeeswaran Ramasamy, Carlson Jennifer H., Ferrone Soldano, Turley Eva A., McCarthy James B., Melanoma Proteoglycan Modifies Gene Expression to Stimulate Tumor Cell Motility, Growth, and Epithelial-to-Mesenchymal Transition, Cancer Research, 69, 19, 2009. Crossref

  143. Wood Laurence M., Guirnalda Patrick D., Seavey Matthew M., Paterson Yvonne, Cancer immunotherapy using Listeria monocytogenes and listerial virulence factors, Immunologic Research, 42, 1-3, 2008. Crossref

  144. Fankhauser Reilly, Chang Matthew, Garrison Zachary, Berryman Rachel, Lucero Olivia M., Fuiten Allison, DePatie Nicholas, Seifert Hilary, Kulkarni Rajan P., Single-Cell Identification of Melanoma Biomarkers in Circulating Tumor Cells, Cancers, 14, 19, 2022. Crossref

Forthcoming Articles

Identification of a novel five-gene prognostic model for laryngeal cancer associated with mitophagy using integrated bioinformatics analysis and experimental verification Dong Song, Lun Dong, Mei Wang, Xiaoping Gao Function of steroid receptor coactivators (SRCs) in T cells and cancers: Implications for cancer immunotherapy Wencan Zhang, Xu Cao, Hongmin Wu, Xiancai Zhong, Yun Shi, Zuoming Sun Electroacupuncture Alleviates Ischemic Stroke by Activating the mTOR/SREBP1 Pathway Jiawang Lang, Jianchang Luo, Luodan Wang, Wenbin Xu, Jie Jia, Zhipeng Zhao, Boxu Lang KIAA1429 induces the m6A modification of LINC01106 to enhance the malignancy of lung adenocarcinoma cell via JAK/STAT3 pathway Di Xu, Ziming Wang, Fajiu Li Effect of p-estrogen receptor at serine on its function and breast growth Yuan Liang, Junhui Qin, Tiancheng Ma, Tong Yang, Zhenyu Ke, Ruian Wang Mechanistic Insights into Tanshinone IIA in the Amelioration of Post-Thyroidectomy Hypoparathyroidism Xiaoyu Qian, Lin Li, Liang Chen, Chao Shen, Jian Tang MiRNA let-7d-5p alleviates inflammatory responses by targeting Map3k1 and inactivating ERK/p38 MAPK signaling in microglia Fan Fang, Cheng Chen Role of Natural Killer Cells as Cell-Based Immunotherapy in Oral Tumor Eradication and Differentiation Both In Vivo and In Vitro Kawaljit Kaur, Anahid Jewett The Current and Future States of Natural Killer Cell-Based Immunotherapy in Hepatocellular Carcinoma Tu Nguyen, Po-Chun Chen, Janet Pham, Kawaljit Kaur, Steven Raman, Anahid Jewett, Jason Chiang Phillygenin alleviated arthritis through the inhibition of NLRP3 inflammasome and Ferroptosis by AMPK Jianghui Wang, Shufang Ni, Kai Zheng, Yan Zhao, peihong zhang, Hong Chang The value of systemic immune-inflammation index and T cell subsets in the severity and prognosis of sepsis Hao Zhou Efficacy and Nuances of Precision Molecular Engineering for Hodgkin's Disease to a Gene Therapeutic Approach Muhammad Imran Qadir, Bilal Ahmed, Nadir Hussain Serum interleukin 6 and ferritin levels are the independent risk factors for pneumonia in elderly patients Hao Yuan, Jing Tian, Lu Wen Exploration of diagnostic markers associated with inflammation in chronic kidney disease (CKD) based on WGCNA and machine learning Qianjia Wu, Yang Yang, Chongze Lin Clinical significance of serum CTRP3 level in the prediction of cardiac dysfunction and intestinal mucosal barrier dysfunction in patients with severe acute pancreatitis Qiang Shao, Lin Sun The protective effect and mechanism of mild hypothermia on pig lung injury after cardiopulmonary resuscitation Jinlin Ren, Fangfang Zhu, Dongdong Sang, Mulin Cong, Shujuan Jiang Exploring mechanism of Zilongjin in treating lung adenocarcinoma based on network pharmacology combined with experimental verification Kang Zhang, Xiaoqun Chen Gastric Cancer Immune Subtypes and Prognostic Modeling: Insights from Aging-Related Genes Analysis Jian Shen, Minzhe Li Effects of different doses of dexmedetomidine on the prevention of postoperative sleep disturbance and serum neurotransmitter level in patients under general anesthesia Huifei Lu, Fei He, Ying Huang, Zhongliang Wei Identification of key ubiquitination-related genes and their associated with immune infiltration in osteoarthritis based on mRNA-miRNA network Dalu Yuan, Hailiang Shen, Lina Bai, Menglin Li, Qiujie Ye Diagnostic and Prognostic value of peripheral neutrophil CD64 index in elderly patients with community-acquired pneumonia Yan Li, Jing Zhang, Suhang Wang, Jie Cao Identification of Metabolism-Related Prognostic Biomarkers and Immune Features of Head and Neck Squamous Cell Carcinoma Rongjin Zhou, Junguo Wang Downregulation of miR-503-5p promotes the development of pancreatic cancer via targeting cyclin E2 Fei Li, Ying-pei Ling, Pan Wang, Shi-cheng Gu, Hao Jiang, Jie Zhu
Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections Prices and Subscription Policies Begell House Contact Us Language English 中文 Русский Português German French Spain